Immune Modulation in Sepsis, ARDS, and Covid-19 — The Road Traveled and the Road Ahead
Aleksandra Leligdowicz, Michael O. Harhay, Carolyn S. Calfee
Abstract
Immune Modulation in Sepsis, ARDS, and Covid-19Leligdowicz et al. consider the history and future of immunomodulating therapies in sepsis and ARDS, including ARDS due to Covid-19, and remark on the larger challenge of clinical research on therapies for syndromes with profound clinical and biologic heterogeneity.
Topics & Concepts
ARDSSepsisCoronavirus disease 2019 (COVID-19)Immune modulationMedicine2019-20 coronavirus outbreakImmune systemIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyVirologyInternal medicineLungOutbreakDiseaseInfectious disease (medical specialty)Respiratory Support and MechanismsIntensive Care Unit Cognitive DisordersSepsis Diagnosis and Treatment